Dr. Scholl's
Product brand
UnclaimedA foot-care and comfort-footwear brand founded in the United States and marketed internationally as Dr. Scholl's or Scholl.
Last updated August 25, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Dr. Scholl's is a foot-care and comfort-footwear brand whose history began in the United States in 1906, when podiatrist William Mathias Scholl established a business focused on products intended to improve foot health and comfort. Scholl is credited with designing more than 1,000 foot-care products over the course of his career, helping establish the brand around the idea that everyday footwear and foot-care products could combine medical knowledge with consumer convenience. The brand developed into a broad product business rather than remaining limited to clinical devices. Its range has included insoles and other shoe inserts, foot-care treatments, comfort footwear, and products intended to address common problems such as pressure, friction, tired feet, and support needs. In North America the name is generally presented as Dr. Scholl's, while in many other markets products have been sold under the shorter Scholl name. This regional split reflected separate ownership and operating arrangements for the American and international businesses for much of the brand's history. The original Scholl company reached a significant corporate milestone in 1971, when it became publicly traded and was included in the Fortune 500. In 1979, Schering-Plough acquired the Dr. Scholl's brand. The brand subsequently became part of Merck & Co. through Merck's 2009 acquisition of Schering-Plough. During the Schering-Plough and Merck period, the product line was imported from China, and footwear distribution in North America was handled under an agreement with the Brown Shoe Company, now known as Caleres. The ownership structure then separated the North American Dr. Scholl's business from the international Scholl business. Bayer obtained the North and South American rights in 2014 as part of its acquisition of Merck's consumer-health unit. In July 2019, Bayer sold the North American Dr. Scholl's business to Yellow Wood Partners for $585 million. Yellow Wood created Scholl's Wellness Company to operate the brand in that region. The international Scholl business followed a different path. In 1984, Schering-Plough sold the global brand and the operations outside North America to European Home Products, later known as SSL International. Reckitt Benckiser acquired SSL International in 2010, thereby acquiring the international Scholl business. In 2014, German investment firm Aurelius acquired the international Scholl Footwear rights from Reckitt, while the American rights remained outside the transaction. In June 2021, Reckitt sold Scholl, including the Amope business, to Yellow Wood Partners. This transaction brought the international Scholl operations and the North American Dr. Scholl's business under common ownership for the first time in more than four decades. Today, Dr. Scholl's is best understood as a global brand family spanning foot comfort, foot care, and footwear. Its market position combines the authority associated with podiatry and orthopedic foot care with mass-market accessibility. The brand's ownership is private, and its global rights are operated through Scholl's Wellness Company under Yellow Wood Partners. Product naming and distribution continue to vary by market, with Dr. Scholl's primarily associated with North America and Scholl used in many international markets.
History
William Mathias Scholl, a podiatrist, founded the business that became Dr. Scholl's in 1906. His professional background shaped the brand's early identity: products were presented as practical solutions to everyday foot discomfort and support needs rather than as ordinary fashion accessories. Scholl is credited with designing more than 1,000 foot-care products, giving the business a broad technical and commercial foundation. Over time, the company expanded from specialist foot-care devices into consumer products including insoles, shoe inserts, treatments, and comfort footwear. This wider assortment allowed the brand to reach consumers through ordinary retail channels while retaining a health-oriented identity. A major corporate milestone came in 1971, when the company became publicly traded and was included in the Fortune 500. The brand's subsequent history was shaped by acquisitions and by the division between its American and international operations. Schering-Plough acquired the Dr. Scholl's brand in 1979. In 1984, Schering-Plough sold the global brand and non-North American operations to European Home Products, which later became SSL International. As a result, the Dr. Scholl's name in North America and the Scholl name in many international markets developed under separate ownership. Reckitt Benckiser acquired SSL International in 2010 and thereby took control of the international Scholl business. In 2014, Aurelius acquired the international Scholl Footwear rights from Reckitt, excluding the Americas. Separately, Bayer acquired the North and South American Dr. Scholl's rights in 2014 as part of its purchase of Merck & Co.'s consumer-health unit. Merck had obtained the brand in 2009 through its acquisition of Schering-Plough. Under the earlier Schering-Plough and Merck arrangements, products were imported from China and North American footwear distribution was conducted through an agreement with Brown Shoe Company, now Caleres. In July 2019, Bayer sold the North American Dr. Scholl's business to Yellow Wood Partners for $585 million. Yellow Wood formed Scholl's Wellness Company as the operating vehicle for the acquired business. The international ownership structure was consolidated in June 2021, when Reckitt sold Scholl, including Amope, to Yellow Wood Partners. That deal reunited the international Scholl activities with the Dr. Scholl's business in North America for the first time in more than forty years. The resulting brand group operates across foot-care products, insoles, support products, and comfort footwear. Its identity combines historical podiatric expertise with broad consumer distribution. Geographic naming remains important: Dr. Scholl's is the principal North American name, while Scholl is used in many markets outside North America. The brand is privately owned through Yellow Wood Partners' Scholl's Wellness Company and remains active.
- 2021
Global rights are reunited under Yellow Wood
[1]Yellow Wood Partners acquires Scholl and Amope from Reckitt, bringing the international and North American businesses under common ownership.
- 2019
Yellow Wood acquires the North American business
[1]Yellow Wood Partners buys the North American Dr. Scholl's business from Bayer for $585 million and establishes Scholl's Wellness Company.
- 2014
Bayer acquires North and South American rights
[1]Bayer obtains the Dr. Scholl's business in North and South America through its acquisition of Merck's consumer-health unit.
- 2014
Aurelius acquires international Scholl Footwear rights
[1]Aurelius acquires the international Scholl Footwear rights from Reckitt, excluding the Americas.
- 2010
Reckitt acquires SSL International
[1]Reckitt Benckiser acquires SSL International and takes ownership of the international Scholl business.
- 2009
Merck acquires the brand through Schering-Plough
[1]Merck & Co. acquires Schering-Plough, bringing the Dr. Scholl's brand into Merck's consumer-health portfolio.
- 1984
International operations are separated
[1]Schering-Plough sells the global brand and non-North American operations to European Home Products, later SSL International.
- 1979
Schering-Plough acquires Dr. Scholl's
[1]Schering-Plough purchases the Dr. Scholl's brand.
- 1971
Public-company and Fortune 500 milestone
[1]The Scholl company becomes publicly traded and is included in the Fortune 500.
- 1906
William Mathias Scholl establishes the business
[1]Podiatrist William Mathias Scholl begins the foot-care business that develops into the Dr. Scholl's brand.
Products and positioning
Comfort, foot health, practical podiatry-informed design, and accessible everyday foot care.
Foot support
Insoles and shoe inserts
Insoles and inserts are a core part of the brand's assortment. They are designed to add cushioning, support, or pressure relief inside ordinary footwear and represent the clearest link between the brand's podiatric heritage and its mass-market consumer proposition.
Personal care
Foot-care products
The brand's foot-care range addresses everyday comfort and common foot concerns through consumer-oriented care products. The category extends the business beyond footwear accessories and reinforces its health and comfort positioning.
Footwear
Comfort footwear
Dr. Scholl's and Scholl footwear applies the brand's comfort-led identity to shoes and other forms of wearable footwear. International operations have marketed footwear under the Scholl name, while North American products have generally used Dr. Scholl's.
Foot care
Amope
Amope is a foot-care brand included in Reckitt's 2021 sale of Scholl to Yellow Wood Partners. Its inclusion helped broaden the portfolio brought under the common Scholl's Wellness Company ownership structure.
Brand decisions
2021
Acquisition of international Scholl and Amope rightsM&ABackground
The international Scholl business had been operated separately from the North American Dr. Scholl's business for more than four decades, with Reckitt holding the international rights before the transaction.
Action taken
Yellow Wood Partners acquired Scholl, including Amope, from Reckitt.
Aftermath
The deal reunited the international Scholl operations with the North American Dr. Scholl's business under common ownership.
2019
Sale of North American Dr. Scholl's rights to Yellow Wood PartnersM&ABackground
Bayer held the Dr. Scholl's business in North and South America after acquiring Merck's consumer-health unit. The business was separated from Bayer through a sale to private-equity firm Yellow Wood Partners.
Action taken
Yellow Wood Partners purchased the North American business for $585 million and established Scholl's Wellness Company to operate it.
Aftermath
The transaction placed the North American brand under independent private ownership and created the platform later used to consolidate the international Scholl business.
Purchase price. $585 million (July 2019)
Recent events
Reported
Dr. Scholl's launches Plantar Fasciitis Pain Relief Sized to Fit Insoles[2]
Dr. Scholl's launched its Plantar Fasciitis Pain Relief Sized to Fit Insoles, a new addition to its Sized to Fit insole line.
Reported
Dr. Scholl's names Dr. Brad Schaeffer brand ambassador[2]
Dr. Scholl's announced a partnership with foot and ankle surgeon Dr. Brad Schaeffer, who will serve as a brand ambassador and help raise awareness of medical conditions and related solutions.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/dr-scholls · Editorial policy · How profiles are compiled